GNH USA

Europe — EMA

Meropenem Sun (Meropenem Anhydrous)

GNH USA supplies Meropenem Sun (Meropenem), a carbapenem antibiotic for intra‑abdominal infections, nosocomial pneumonia and meningitis. Request a quote.

Meropenem Anhydrous

Request sourcing

1
Pack/s

What is Meropenem Anhydrous?

Meropenem, the active ingredient in Meropenem Sun, is a carbapenem antibiotic presented as an injectable formulation for intravenous use. It provides broad‑spectrum antibacterial activity against Gram‑negative and Gram‑positive pathogens and is employed in severe hospital‑acquired infections.

GNH USA supplies Meropenem Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, adhering to stringent quality standards and delivering the product across multiple continents.

What is Meropenem Anhydrous used for?

Meropenem is used to treat serious bacterial infections that affect the abdominal, urinary, respiratory and central nervous systems.

Complicated intra‑abdominal infections: eliminates causative bacteria and improves clinical outcomes. Complicated urinary tract infections: eradicates resistant uropathogens and resolves infection. Nosocomial pneumonia: provides rapid bacterial clearance in hospital‑acquired lung infections. Septicemia: achieves systemic bacterial control and reduces mortality risk. Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis effectively.

What are the side effects of Meropenem Anhydrous?

Adverse reactions to Meropenem may vary in frequency and severity.

Common Side Effects: - Nausea or vomiting - Diarrhea, including mild C. difficile‑associated colitis - Headache - Infusion site erythema or phlebitis

Serious or Rare Side Effects: - Seizures, especially in patients with renal impairment - Anaphylactic or severe hypersensitivity reactions - Severe C. difficile‑associated colitis - Neutropenia or thrombocytopenia - Elevated liver enzymes indicating hepatic injury

What precautions apply to Meropenem Anhydrous?

When prescribing Meropenem, clinicians should consider several safety and handling precautions. - Renal impairment: adjust dose based on creatinine clearance. - Hepatic dysfunction: monitor liver function tests during therapy. - History of seizures: use with caution as the drug may lower seizure threshold. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Drug interactions: review concomitant medications for potential interactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Meropenem Anhydrous interact with?

Meropenem can interact with other medicines, affecting efficacy or toxicity.

Major Interactions (Avoid): - Valproic acid: reduced serum levels may precipitate seizure breakthrough. - Probenecid: increased meropenem concentrations can raise toxicity risk. - Cytotoxic agents (e.g., cyclophosphamide): additive nephrotoxicity may occur.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Aminoglycosides: watch for combined nephrotoxic effects. - Anticoagulants (warfarin): monitor INR for potential alteration of anticoagulant effect.

Frequently asked questions

What is Meropenem Sun used for?+
Meropenem Sun is an intravenous carbapenem antibiotic indicated for the treatment of severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired (nosocomial) pneumonia, septicemia and bacterial meningitis.
How does meropenem work?+
Meropenem inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, blocking the final cross‑linking step of peptidoglycan formation. This leads to weakened cell walls, osmotic instability and bacterial lysis, providing broad‑spectrum activity against many resistant Gram‑negative and Gram‑positive organisms.
What determines the dose of Meropenem Sun?+
The prescribed dose of Meropenem Sun is determined by the treating physician based on the type and severity of infection, patient weight, renal and hepatic function, and local antimicrobial susceptibility patterns. No fixed regimen is provided here.
Is Meropenem Sun safe during pregnancy or breastfeeding?+
Safety data for Meropenem Sun in pregnancy and lactation are limited. It is classified as pregnancy category unknown, and use is recommended only when the potential benefit justifies the potential risk to the fetus or infant.
How do I order Meropenem Sun from GNH USA?+
To order Meropenem Sun, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Meropenem compare with other carbapenems or alternative antibiotics?+
Meropenem offers a broad spectrum of activity similar to other carbapenems like imipenem and ertapenem, but it is more stable against many beta‑lactamases and provides reliable coverage for both Gram‑negative and Gram‑positive pathogens, making it a preferred option for multidrug‑resistant infections.
How should Meropenem Sun be stored and handled?+
Meropenem Sun should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Once reconstituted, it should be used within the time frame specified in the product labeling and kept under the same temperature conditions.
How is Meropenem Sun administered?+
Meropenem Sun is administered by intravenous infusion. The infusion rate and duration are determined by the prescribing clinician, typically over 15‑30 minutes, and may be adjusted based on patient tolerance and clinical response.
What are the most serious risks associated with Meropenem Sun?+
Serious risks include the potential for seizures, especially in patients with renal impairment, severe hypersensitivity reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis, which can be life‑threatening if not promptly recognized and treated.
Who should not receive Meropenem Sun?+
Meropenem Sun should be avoided in patients with a known hypersensitivity to meropenem, other carbapenems, or any beta‑lactam antibiotics. Caution is also advised for patients with a history of seizures, severe renal impairment, or those receiving interacting medications listed under major interactions.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Meropenem Anhydrous
Route
Intravenous Use
Manufacturer
Sun Pharmaceutical Industries Europe B.V.
Origin
EU

Related products

Agenor

Agenor

Meropenem Anhydrous

Medochemie Ltd.
EU
Agenorem

Agenorem

Meropenem Anhydrous

Medochemie Ltd.
EU
Archifar

Archifar

Meropenem Anhydrous

Medochemie Ltd.
EU
Archifar

Archifar

Meropenem Anhydrous

Medochemie Ltd.
EU